Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Barbara Lattanzi
Observed names:
B Lattanzi,
B. Lattanzi,
BARBARA LATTANZI,
Barbara LATTANZI
Institution:
Ospedale Sandro Pertini
Observed institutions:
University of Modena and Reggio Emilia,
University of Alberta,
Policlinico Umberto I,
St George’s University Hospitals NHS Foundation Trust,
University of Chieti-Pescara,
General Hospital of Shenyang Military Region,
Ospedale Sandro Pertini,
Sapienza University of Rome
show all 8
ORCID:
0000-0003-2685-6504
Observed ORCID:
0000-0003-2685-6504
OpenAlex ID:
A5047612096
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide
2018
·
Salvatore Piano
, Virendra Singh
, et al.
·
Gastroenterology
·
551
PDF
Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study
2012
·
Manuela Merli
, Michela Giusto
, et al.
·
Metabolic Brain Disease
·
254
Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement
2016
·
Silvia Nardelli
, Barbara Lattanzi
, et al.
·
Clinical Gastroenterology and Hepatology
·
211
Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry
2015
·
Michela Giusto
, Barbara Lattanzi
, et al.
·
European Journal of Gastroenterology & Hepatology
·
177
Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis
2019
·
Silvia Nardelli
, Barbara Lattanzi
, et al.
·
Hepatology
·
173
PDF
Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt
2019
·
Michael Praktiknjo
, Caroline Clees
, et al.
·
Clinical and Translational Gastroenterology
·
126
Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis
2019
·
Javier Fernández
, Paolo Angeli
, et al.
·
Clinical Gastroenterology and Hepatology
·
118
PDF
The Spread of Multi Drug Resistant Infections Is Leading to an Increase in the Empirical Antibiotic Treatment Failure in Cirrhosis: A Prospective Survey
2015
·
Manuela Merli
, Cristina Lucidi
, et al.
·
PLoS ONE
·
107
PDF
Increased risk of cognitive impairment in cirrhotic patients with bacterial infections
2013
·
Manuela Merli
, Cristina Lucidi
, et al.
·
Journal of Hepatology
·
98
The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS
2019
·
Stefania Gioia
, Manuela Merli
, et al.
·
Liver International
·
80
An empirical broad spectrum antibiotic therapy in health‐care–associated infections improves survival in patients with cirrhosis: A randomized trial
2015
·
Manuela Merli
, Cristina Lucidi
, et al.
·
Hepatology
·
80
Hepatic Encephalopathy and Sarcopenia: Two Faces of the Same Metabolic Alteration
2018
·
Barbara Lattanzi
, Daria D’Ambrosio
, et al.
·
Journal of Clinical and Experimental Hepatology
·
69
A low muscle mass increases mortality in compensated cirrhotic patients with sepsis
2018
·
Cristina Lucidi
, Barbara Lattanzi
, et al.
·
Liver International
·
64
Diagnosis and Management of Esophagogastric Varices
2023
·
Socrate Pallio
, Giuseppinella Melita
, et al.
·
Diagnostics
·
63
PDF
The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease
2019
·
Barbara Lattanzi
, Silvia Nardelli
, et al.
·
Digestive and Liver Disease
·
60
Liver transplantation for severe alcoholic hepatitis: A multicenter Italian study
2021
·
Giacomo Germani
, Debora Angrisani
, et al.
·
American Journal of Transplantation
·
59
Donor-to-recipient gender match in liver transplantation: A systematic review and meta-analysis
2018
·
Quirino Lai
, Francesco Giovanardi
, et al.
·
World Journal of Gastroenterology
·
54
Sarcopenic obesity in fatty liver
2019
·
Manuela Merli
, Barbara Lattanzi
, et al.
·
Current Opinion in Clinical Nutrition & Metabolic Care
·
50
PDF
Hepatic encephalopathy expands the predictivity of model for end‐stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts
2016
·
Cristina Lucidi
, Stefano Ginanni Corradini
, et al.
·
Liver Transplantation
·
46
PDF
The Effects of 12-Week Beta-Hydroxy-Beta-Methylbutyrate Supplementation in Patients with Liver Cirrhosis: Results from a Randomized Controlled Single-Blind Pilot Study
2021
·
Barbara Lattanzi
, Angelo Bruni
, et al.
·
Nutrients
·
39
PDF
The multidisciplinary support in preventing alcohol relapse after liver transplantation: A single‐center experience
2018
·
Maria Luisa Attilia
, Barbara Lattanzi
, et al.
·
Clinical Transplantation
·
39
The Effect of 12 Weeks of β-Hydroxy-β-Methyl-Butyrate Supplementation after Liver Transplantation: A Pilot Randomized Controlled Study
2019
·
Barbara Lattanzi
, Michela Giusto
, et al.
·
Nutrients
·
37
PDF
Beta-blockers in liver cirrhosis.
2014
·
Valerio Giannelli
, Barbara Lattanzi
, et al.
·
PubMed Central
·
34
PDF
Prevalence and impact of sarcopenia in non‐cirrhotic portal hypertension
2019
·
Barbara Lattanzi
, Stefania Gioia
, et al.
·
Liver International
·
27
Weight Gain and De Novo Metabolic Disorders after Liver Transplantation
2019
·
Barbara Lattanzi
, Daria D’Ambrosio
, et al.
·
Nutrients
·
24
PDF
Show more works
View as search
Works count:
95
Citation count:
2,813
H-index:
24
I10-index:
33
Year
Topic
Type
